| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,001 | 0,002 | 22:28 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.01. | Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development with Multi-Center PH-ILD Study | 3 | GlobeNewswire (USA) | ||
| 12.01. | Polarean Highlights New CHEST Journal Study Demonstrating Xenon MRI Predicts Cystic Fibrosis Exacerbations | 3 | GlobeNewswire (USA) | ||
| POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
| 29.12.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 29.12.2025 | 1.565 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 29.12.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 29.12.2025ISIN NameAU0000111395 PROSPECH... ► Artikel lesen | |
| 24.12.25 | Polarean Imaging and OPG Power Ventures start trading on JP Jenkins | 8 | Alliance News | ||
| 23.12.25 | XFRA 8ZF: AUSSETZUNG/SUSPENSION | 180 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPOLAREAN IMAG.LS-... ► Artikel lesen | |
| 23.12.25 | AIM - Cancellation - Polarean Imaging Plc | 2 | RNS | ||
| 17.12.25 | FTSE Russell - Polarean Imaging: Constituent Deletion - Changes in FTSE UK Index Series | 2 | RNS | ||
| 15.12.25 | Polarean to delist from AIM following shareholder approval | 3 | Investing.com | ||
| 15.12.25 | Polarean Imaging: Aktionäre stimmen für Delisting vom AIM | 4 | Investing.com Deutsch | ||
| 15.12.25 | Polarean Imaging PLC - Result of General Meeting | 2 | RNS | ||
| 01.12.25 | Polarean: XENOVIEW 3T coil passes Philips compatibility testing | 1 | GlobeNewswire (USA) | ||
| 01.12.25 | Polarean: XENOVIEW-Brustspule mit Philips-MRT-Systemen kompatibel | 12 | Investing.com Deutsch | ||
| 01.12.25 | Polarean's chest coil compatible with Philips MRI systems | 3 | Investing.com | ||
| 01.12.25 | Polarean Imaging PLC - Chest coil passes Philips compatibility testing | 1 | RNS | ||
| 25.11.25 | Polarean Imaging PLC - First Xenon Hyperpolariser in Asia | - | RNS | ||
| 24.11.25 | IN BRIEF: Polarean Imaging signs exclusive Xenon distribution deal | 3 | Alliance News | ||
| 24.11.25 | Polarean: Korean distributor agreement with DK Healthcare in South Korea | 2 | GlobeNewswire (USA) | ||
| 24.11.25 | Polarean Imaging signs distribution deal in South Korea | 1 | Sharecast | ||
| 24.11.25 | Polarean Imaging PLC - Korean distributor agreement with DK Healthcare | - | RNS | ||
| 17.11.25 | Polarean Imaging plans AIM exit as seeks USD20 million funding | 2 | Alliance News |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 83,94 | +1,56 % | Medtronic Launches MiniMed Go Smart MDI System In Europe | WASHINGTON (dpa-AFX) - Medtronic (MDT) announced the commercial launch in Europe of the MiniMed Go Smart MDI system with the Simplera sensor. The launch will be rolled out gradually across Europe... ► Artikel lesen | |
| HCA HEALTHCARE | 455,70 | +1,65 % | How Is HCA Healthcare's Stock Performance Compared to Other Healthcare Providers Stocks? | ||
| LANTHEUS | 64,58 | +1,86 % | Lantheus Holdings, Inc.: Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | Worldwide revenue of $406.8 million and $1.54 billion for the fourth quarter and full year 2025GAAP fully diluted earnings per share of $0.82 and $3.41 for the fourth quarter and full year 2025Adjusted... ► Artikel lesen | |
| ENVISTA | 24,200 | +0,83 % | Envista Holdings Corporation: Envista Reports Fourth Quarter 2025 Results | BREA, Calif., Feb. 5, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended December 31, 2025.
"With our... ► Artikel lesen | |
| CAREDX | 16,000 | +1,36 % | BTIG raises CareDx stock price target to $26 on strong Q4 results | ||
| GT BIOPHARMA | 0,460 | -2,02 % | GT Biopharma, Inc.: GT Biopharma Reports Full Year 2025 Financial Results | Phase 1 trial evaluating GTB-3650 TriKE- continues to actively enroll, with the next update anticipated in Q3 2026 following completion of enrollment in dose Cohort 5 Phase 1 basket trial evaluating... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Second Quarter Fiscal Year 2026 Results | Reports 14% Increase in ARR to $21.8 Million, Net Income of $547,000 and 36% Year-over-Year Growth in Adjusted EBITDA
HENDERSON, Nev., Feb. 12, 2026 /PRNewswire/... ► Artikel lesen | |
| CARMAT | 0,099 | -100,00 % | CARMAT Provides an Update on the Ongoing Receivership Procedure | The Versailles Economic Court has opted for the takeover bid within the context of a sales plan submitted by CARMAT SAS and approved the sale plan1 of CARMAT SA to CARMAT SAS
Regulatory News:
CARMAT... ► Artikel lesen | |
| CHEMOMETEC | 54,30 | -3,12 % | Chemometec A/S: Notification of managers' transactions | ||
| DEVYSER DIAGNOSTICS | 8,530 | -0,23 % | Devyser Diagnostics AB: Devyser Diagnostics AB publishes year-end report for January to December 2025 | "The fourth quarter confirmed the positive earnings trend that we have seen throughout the year. Operating profit amounted to SEK 18.0 million (-3.7) for the quarter and to SEK 10.1 million (-62.3)... ► Artikel lesen | |
| ARRAIL GROUP | 0,203 | -100,00 % | ARRAIL GROUP (06639): QUARTERLY UPDATE AND CONTINUED SUSPENSION OF TRADING | ||
| SIEMENS HEALTHINEERS | 41,370 | -2,41 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| FRESENIUS | 50,78 | -1,05 % | Dax-Konzern liefert: Fresenius legt starkes Jahresergebnis vor und erhöht die Dividende | © Foto: Arne Dedert/dpaEin starkes Schlussquartal treibt Fresenius zu soliden Jahreszahlen und höherer Dividende, doch die Aktie reagiert mit Verlusten.Der Gesundheitskonzern Fresenius hat im Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,840 | +1,58 % | Fresenius Medical Care: Hohe Kursverluste trotz starker Quartalszahlen | Die UBS bleibt bei ihrer Verkaufsempfehlung für Fresenius Medical Care und warnt vor zu optimistischen Markterwartungen für die kommenden Jahre. Trotz eines starken Quartals sieht die Großbank weiterhin... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,800 | -5,43 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen |